FHTXNasdaq United States
Market cap
$356.394 M
$6.07 +8.98%
Close of 7 Aug 2026
Revenue
$30.9M
#2887 by revenue
Earnings
-$74.3M
Loss-making
Shares outstanding
59,385,315
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Foghorn Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.